Looking to publish in Therapeutic Advances in Chronic Disease? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowTherapeutic Advances in Chronic Disease is a peer-reviewed open access journal focused on high-quality research, reviews, and scholarly commentary on innovative studies across chronic diseases, with a strong clinical and pharmacological emphasis for clinicians and researchers.
Looking to publish in Therapeutic Advances in Chronic Disease? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Therapeutic Advances in Chronic Disease accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
Scoping Reviews
Systematic Reviews
Meta-Analyses
Case Reports
Case Series
Brief Reports
Letters To The Editor
Recent Publications
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
David Rosmarin, Thierry Passeron, Amit G. Pandya, Pearl Grimes, John E. Harris, Seemal R. Desai, Mark Lebwohl, Mireille Ruer‑Mulard, Julien Seneschal, Albert Wolkerstorfer, Deanna Kornacki, Kang Sun, Kathleen Butler, Khaled Ezzedine
The evolving roles of fetuin-A in type 2 diabetes mellitus and its potential clinical implications: a review
Mohammed Jemal, Nuredin Chura Waritu, Temesgen Baylie, Deresse Sinamaw, Enyew Fenta Mengistu, Enatnesh Essa Osman, Gelagey Baye, Bantayehu Addis Tegegne, Gashaw Azanaw Amare, Zigale Hibstu Teffera, Tabarak Malik, Birhanu Malede, Baye Ashenef, Desalegn Abebaw, Adane Adugna
The relationship between MAFLD and CVD in a health check-up Chinese population: a prospective cohort study
Yao Dou, Jiawei Cui, Qi Gu, Xiwei Yuan, Mengmeng Hou, Wenjing Ni, Chen Dong, Chudi Chang, Jinhua Shao, Qiuling Wang, Jie Li, Liang Qiao, Yuemin Nan
Short- and long-term complications of insulin pump therapy in children and adolescents with type 1 diabetes: a multicenter cross-sectional study from Saudi Arabia
Ayman Bakkar, Enad Althobaiti, Ibtisam Alqahtani, Lujain A Abualkhair, Naglaa M Kamal, Mohammed Althobaiti, Turki Alotaibi, Lura Habib, Lujain Alharthi, Saad Aljuaid, Maha Althuwaybi, Haneen Alshehri, Muhannad Alotaibi, Wael Kamal, Mutlaq Aljuaid, Samia Almalki, Abdulaziz Alsaedi
Level of medication non-adherence among ambulatory patients with dyslipidemia and comorbid illness in Northwest Ethiopia: a multicenter cross-sectional study
Tilaye Arega Moges, Samuel Berihun Dagnew, Sisay Sitotaw Anberbr, Bayih Endalew Bitew, Mekdes Kiflu, Yared Andargie Ferede, Tesfagegn Gobezie Yiblet, Woretaw Sisay Zewdu
Frequently asked questions
How long does it take to publish?
Accepted articles can appear online within an average of 30 days after the APC has been processed.
Reformat to Therapeutic Advances in Chronic Disease using Livewrite PremiumIs a cover letter required?
A cover letter is required and should explain why the manuscript is suitable for publication. Writing assistance or third-party submission must also be disclosed in the covering letter.
Reformat to Therapeutic Advances in Chronic Disease using Livewrite PremiumWhat are the publication costs?
The journal is open access. The standard APC is $3000 USD, payable after acceptance and before publication. Editorials and Letters to the Editor are free of charge. Plain Language Summary of Publications (PLS-Ps) have an APC of $5000.
Reformat to Therapeutic Advances in Chronic Disease using Livewrite Premium